Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane osmotic gradients across renal tubular and tissue cell membranes are physiological gradients of solute concentration (primarily sodium, chloride, and urea) that facilitate the movement of water across semi-permeable membranes in the kidney (StatPearls, Physiology, Renal Osmotic Gradient, 2023). These gradients are established by the countercurrent multiplier system in the Loop of Henle and are essential for the kidney's ability to concentrate urine and maintain fluid homeostasis (Guyton and Hall Textbook of Medical Physiology, 14th Ed). While not a single molecular entity, these gradients are maintained by the coordinated action of transporters like the Na-K-2Cl symporter (NKCC2) and water channels like Aquaporin-2 (PubMed, PMID: 11487034). Pharmacological agents such as loop diuretics (e.g., Furosemide) work by inhibiting these transporters, thereby dissipating the medullary osmotic gradient and increasing water excretion (PubChem, CID 3440). Conversely, vasopressin receptor antagonists (vaptans) modulate the gradient's effect on water reabsorption to treat electrolyte imbalances like hyponatremia (NIH, LiverTox: Vaptans). The maintenance of these gradients is also influenced by urea recycling and the vasa recta's countercurrent exchange mechanism, which prevents the washout of solutes from the medullary interstitium. Disruptions in these gradients are central to the pathophysiology of various renal and systemic disorders, including diabetes insipidus and chronic kidney disease.
Drugs modulate the activity of specific transporters (e.g., NKCC2, SGLT2) or water channels (e.g., Aquaporins) to alter solute and water movement, thereby increasing or decreasing the osmotic pressure across renal membranes (StatPearls, 2023; PubMed, PMID: 11487034).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane osmotic gradients across renal tubular and tissue cell membranes.